Hyaluronic acid and a corticosteroid in one formulation: Cingal by Anika Therapeutics combines cross-linked hyaluronic acid with triamcinolone hexacetonide. This preparation is intended for professional intra-articular treatment of knee osteoarthritis. At Novamedo, you will find the version with a 4 ml pre-filled syringe.
What distinguishes Cingal?
Cingal combines two components with different properties: sodium hyaluronate as the basis for viscosupplementation and triamcinolone hexacetonide as a corticosteroid. The corticosteroid has anti-inflammatory properties.
This composition distinguishes Cingal from preparations without a corticosteroid. The medical selection takes into account the condition of the joint, possible contraindications, and the current manufacturer's instructions for use.
Composition of the 4 ml syringe
The pre-filled syringe offered contains:
- 88 mg sodium hyaluronate in 4 ml, corresponding to 22 mg/ml,
- 18 mg triamcinolone hexacetonide in 4 ml, corresponding to 4.5 mg/ml.
The pack includes one sterile, ready-to-use 4 ml pre-filled syringe.
Professional use for knee osteoarthritis
Cingal is aimed at appropriately qualified medical professionals for intra-articular applications in knee osteoarthritis. The corticosteroid component it contains is part of the physician's benefit-risk assessment and treatment planning.
Further preparations for practice needs
At Novamedo, you will also find Durolane with NASHA technology, Synvisc-One with Hylan G-F 20, and Ostenil Plus with sodium hyaluronate and mannitol. The different formulations are selected according to the respective planned medical application.
Order Cingal from Novamedo
Discover Cingal 4 ml for your professional practice needs. The product page leads directly to the details, the currently displayed price, and online ordering at Novamedo.
For use by qualified medical professionals. Please observe the current manufacturer's instructions for use regarding indications, contraindications, precautions, application, and safety.












